A jury ordered Abbott Laboratories to pay $495 million in compensation and damages after determining that the company failed ...

(Bloomberg) -- Abbott Laboratories hid the risks of its premature-infant formula causing a potentially fatal bowel disease from parents even though company officials acknowledged the peril in ...

The lawsuit accuses Abbott of creating products called “transition formulas,” “follow-on formulas,” “weaning formulas” and “toddler milks” to boost earnings as infant formula sales ...

A year after the American Academy of Pediatrics flagged what it described as "questionable marketing practices" by makers of formulas for older infants and toddlers, Abbott Laboratories is being ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...

LANSING, Mich. — Sen. Gary Peters has reintroduced a bill designed to stop future infant formula shortages from happening. The bipartisan legislation was drafted after a nationwide shortage in 2022 ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks on Jim Cramer's radar. Jim Cramer, host of Mad Money, recently emphasized the ...

Abbott and Reckitt unit secure win in infant formula trial Legalcategory· November 1, 2024 Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company ...